FT001 Fungitell (1→3)-β-D- Glucan Assay Kit - 110 test wells

The Fungitell^® assay is a highly sensitive, microplate-based test that detects (1→3)-β-D-Glucan in serum. (1→3)-β-D-Glucan is a cell wall constituent of most medically important fungi including Candida and Aspergillus.* (1→3)-β-D-Glucan is normally found at low levels in the blood of healthy humans. In at risk patients, serum (1→3)-β-D-Glucan values of at least 80 pg/mL, are highly associated with invasive fungal infection. Conversely, low levels of (1→3)-β-D-Glucan have a high negative predictive value for invasive fungal infection. (1→3)-β-D-Glucan detection is not subject to the usual interferences. It is not suppressed by anti-fungal therapy, nor is the test cross-reactive with other polysaccharides.

Benefits Of The Fungitell Assay compared to conventional diagnostic methods, the Fungitell assay provides a rapid, reliable and near pan fungal8 marker for early IFI screening:

• Early Indication – glucan becomes elevated well in advance of conventional signs/symptoms of IFI
• Rapid Results – assay provides results in less than 1 hour
• Strong Negative Predictive Value (NPV) – highly effective in ruling
• out the presence of IFI9,10,11
• (1g3)-b-D-Glucan Detection – not suppressed by anti-fungal therapy;
• a mycology criterion for the purposes of supporting the classification of
• “probable” IFD per the EORTC/MSG Consensus Group
• Anti-Microbial Stewardship – consecutive negative tests may reduce
• the overuse of antifungals, help combat the emergence of anti-fungal
• resistance, ensure better patient outcomes and promote cost savings.
• Cost savings associated with candidaemia alone can range from
• between $25,000-$55,000.12
• Longevity in the Marketplace – over a decade of proven clinical use,
• 100+ peer-reviewed clinical papers